Ambry Genetics, a wholly owned subsidiary of Tempus AI (NASDAQ:TEM), has introduced GenomeNext and GenomeReveal, a new whole ...

Long-read DNA testing diagnosed 35% of previously unsolved inherited muscle disease cases, detecting complex genetic changes ...

TEL AVIV, Israel & LEHI, Utah & HOUSTON & FREMONT, Calif., October 14, 2025--(BUSINESS WIRE)--MyHeritage, the leading global platform for family history and DNA testing, announced today a landmark ...

Clinicians should prioritize genetic testing for young children who show signs of intellectual disability (ID) or developmental delays, according to a new report from the American Academy of ...

A variant in the NCF1 gene, a pharmacogenomic finding about voriconazole, in the Dante Labs reports provided a precise ...

For more than 12 years, Abbott's cancer diagnostics business has helped expand access to colorectal cancer screening through ...

Ambry Genetics, a leader in clinical genomic testing and a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), today announced the launch of GenomeNext™ and GenomeReveal™, a comprehensive whole ...

For most of her life, Christy Krauss didn't like looking at herself in the mirror. She liked the digits on the scale even ...

A Mayo Clinic study published in the Journal of Neuro-Oncology suggests that analyzing DNA in cerebrospinal fluid could provide another source of information when MRI cannot provide a clear brain ...